| # | Title | Journal | Year | Citations |
|---|
| 1 | Nose-to-brain peptide delivery – The potential of nanotechnology | Bioorganic and Medicinal Chemistry | 2018 | 113 |
| 2 | Modulating the immune system through nanotechnology | Seminars in Immunology | 2017 | 90 |
| 3 | Polysaccharide Nanoparticles Can Efficiently Modulate the Immune Response against an HIV Peptide Antigen | ACS Nano | 2019 | 61 |
| 4 | Structure‐Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics | ChemMedChem | 2016 | 51 |
| 5 | New scaffolds encapsulating TGF-β3/BMP-7 combinations driving strong chondrogenic differentiation | European Journal of Pharmaceutics and Biopharmaceutics | 2017 | 43 |
| 6 | In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic | Neurochemistry International | 2016 | 35 |
| 7 | A 2D-DIGE-based proteomic analysis reveals differences in the platelet releasate composition when comparing thrombin and collagen stimulations | Scientific Reports | 2015 | 32 |
| 8 | A multifunctional drug nanocarrier for efficient anticancer therapy | Journal of Controlled Release | 2019 | 29 |
| 9 | A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: implications for CLEC-2 signaling regulation | Blood | 2012 | 25 |
| 10 | An In Situ Hyaluronic Acid-Fibrin Hydrogel Containing Drug-Loaded Nanocapsules for Intra-Articular Treatment of Inflammatory Joint Diseases | Regenerative Engineering and Translational Medicine | 2020 | 24 |
| 11 | Proteomic analysis of extracellular vesicles derived from platelet concentrates treated with Mirasol® identifies biomarkers of platelet storage lesion | Journal of Proteomics | 2020 | 23 |
| 12 | Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors | Frontiers in Immunology | 2020 | 23 |
| 13 | Engineering, on‐demand manufacturing, and scaling‐up of polymeric nanocapsules | Bioengineering and Translational Medicine | 2019 | 22 |
| 14 | Pore size is a critical parameter for obtaining sustained protein release from electrochemically synthesized mesoporous silicon microparticles | PeerJ | 2015 | 20 |
| 15 | Using nanotechnology to deliver biomolecules from nose to brain — peptides, proteins, monoclonal antibodies and RNA | Drug Delivery and Translational Research | 2022 | 20 |
| 16 | Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs | European Journal of Medicinal Chemistry | 2019 | 19 |
| 17 | Molecular Proteomics and Signalling of Human Platelets in Health and Disease | International Journal of Molecular Sciences | 2021 | 19 |
| 18 | 2D‐DIGE‐based proteomic analysis of intracoronary versus peripheral arterial blood platelets from acute myocardial infarction patients: Upregulation of platelet activation biomarkers at the culprit site | Proteomics - Clinical Applications | 2016 | 18 |
| 19 | Synthetic nanocarriers for the delivery of polynucleotides to the eye | European Journal of Pharmaceutical Sciences | 2017 | 17 |
| 20 | Engineering Anisotropic Meniscus: Zonal Functionality and Spatiotemporal Drug Delivery | Tissue Engineering - Part B: Reviews | 2021 | 17 |
| 21 | Polyphosphazenes for the delivery of biopharmaceuticals | Journal of Applied Polymer Science | 2020 | 16 |
| 22 | Platelet clinical proteomics: Facts, challenges, and future perspectives | Proteomics - Clinical Applications | 2016 | 15 |
| 23 | Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches | Scientific Reports | 2016 | 14 |
| 24 | Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation | Journal of Thrombosis and Haemostasis | 2020 | 14 |
| 25 | N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic | Biomolecules | 2020 | 14 |
| 26 | Tailored Hydrogels as Delivery Platforms for Conditioned Medium from Mesenchymal Stem Cells in a Model of Acute Colitis in Mice | Pharmaceutics | 2021 | 14 |
| 27 | Technological challenges in the preclinical development of an HIV nanovaccine candidate | Drug Delivery and Translational Research | 2020 | 13 |
| 28 | Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues | Advanced Functional Materials | 2021 | 13 |
| 29 | Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin | Molecules | 2022 | 13 |
| 30 | Deciphering the secretome of leukocyte-platelet rich fibrin: towards a better understanding of its wound healing properties | Scientific Reports | 2020 | 12 |
| 31 | Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques | PLoS ONE | 2018 | 11 |
| 32 | Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1H-indole (D2AAK1_3) as Dopamine D2 Receptor Ligand | Molecules | 2018 | 11 |
| 33 | N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand | Neurochemistry International | 2021 | 10 |
| 34 | Enhancing cutaneous delivery with laser technology: Almost there, but not yet | Journal of Controlled Release | 2019 | 8 |
| 35 | Laser-induced transient skin disruption to enhance cutaneous drug delivery | European Journal of Pharmaceutics and Biopharmaceutics | 2020 | 8 |
| 36 | Vaccine targeting SIVmac251 protease cleavage sites protects macaques against vaginal infection | Journal of Clinical Investigation | 2020 | 7 |
| 37 | Exploring the potential of platelet proteomics in children | Proteomics - Clinical Applications | 2014 | 5 |
| 38 | Platelet proteomics applied to the search for novel antiplatelet therapeutic targets | Expert Review of Proteomics | 2016 | 5 |
| 39 | Extracellular vesicles in the transfusion medicine field: The potential of proteomics | Proteomics | 2021 | 5 |
| 40 | Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications | Pharmacological Reports | 2022 | 5 |
| 41 | Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist | Thrombosis and Haemostasis | 2022 | 5 |
| 42 | Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety | ChemMedChem | 2022 | 5 |
| 43 | Cervico-Vaginal Inflammatory Cytokine and Chemokine Responses to Two Different SIV Immunogens | Frontiers in Immunology | 2020 | 3 |
| 44 | The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile | Frontiers in Pharmacology | 2022 | 3 |
| 45 | In vitro and in vivo evaluation of antioxidant and neuroprotective properties of antipsychotic D2AAK1 | Neurochemical Research | 2022 | 2 |
| 46 | Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties | Molecules | 2022 | 1 |
| 47 | Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder | | 0 | 0 |
| 48 | Structural and biological evaluation of novel multi-target compound with potential application in the treatment of schizophrenia | | 0 | 0 |
